ACB.TO Aurora Cannabis (TSX) 04 Feb 2026 pre-market: earnings due, key forecast

ACB.TO stock is trading at C$5.55 pre-market as Aurora Cannabis Inc. prepares to report earnings on 04 Feb 2026. The company will release results at 08:30 EST / 13:30 UTC, and investors are watching cash, margins, and inventory after recent margin improvements. Today’s report should move the stock given the company’s C$313.99M market cap and elevated short-term trading volume.

ACB.TO stock: What to expect in the 04 Feb 2026 earnings report

Aurora Cannabis (ACB.TO) will publish results on 04 Feb 2026 at 08:30 EST. Analysts will look for revenue trends, gross margin, and any update to guidance. Market focus will be on inventory days, cash per share, and whether operating cash flow improves versus the last quarter. If management highlights stronger European distribution or cost cuts, the stock could gap higher on the open.

ACB.TO stock: Key financials and ratios to watch

Current price is C$5.55 with a 1-day change of +3.16%. Reported EPS stands at -1.01 and trailing PE is shown as -5.50 in the quote data. Important ratios for today: price/50-day = C$6.19, price/200-day = C$6.70, book value per share = C$10.73, and current ratio = 2.97. These figures highlight low valuation versus book value and a liquid balance sheet that can absorb short-term volatility.

ACB.TO stock: Technical and trading snapshot before the print

Pre-market volume is modest versus average at 498,000 shares traded versus an avg of 559,840. Technical indicators show RSI 40.24 and MACD slightly negative, signalling limited upside momentum ahead of results. Bollinger bands place the lower band at C$5.21 and the middle at C$6.47, framing risk if guidance disappoints. Watch intraday volume spikes for confirmation of trend.

ACB.TO stock: Meyka AI grade and model forecast

Meyka AI rates ACB.TO with a score out of 100: 66.33 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of C$8.17, a quarterly target of C$7.30, and a monthly target of C$8.03. Compared with the current price of C$5.55, the yearly projection implies an upside of +47.24%. These forecasts are model-based projections and not guarantees. These grades are not guaranteed and we are not financial advisors.

ACB.TO stock: Valuation, sector context and peer comparison

Aurora sits in the Canadian Healthcare sector where peers trade at higher PE and PB multiples on average. Sector metrics show an average PE around 22.68 and average PB near 2.29, while ACB.TO shows a low price-to-book near 0.55, indicating a discount to book. Inventory days remain high and margins are improving, so valuation hinges on sustained margin expansion and sales growth in Canada and Europe.

ACB.TO stock: Catalysts, risks and what traders should monitor

Catalysts today include explicit guidance, European rollout updates, and commentary on wholesale demand. The company recently launched new European websites, which could support international growth source. Key risks: continued negative EPS, inventory build, and a weak consumer market. Monitor the company’s commentary and any revisions to capital allocation or buyback language, and watch MarketBeat summaries for market reaction source. For more detail visit our internal Aurora page at Meyka ACB.TO page.

Final Thoughts

ACB.TO stock enters the 04 Feb 2026 earnings window with C$5.55 in price and an earnings release scheduled for 08:30 EST. The report will be a near-term driver; investors should weigh operational updates against a balance sheet that shows C$3.39 cash per share and book value C$10.73. Meyka AI’s forecast model projects a yearly target of C$8.17, implying +47.24% upside versus the current price. Tradeflows will hinge on management guidance on margins, European expansion, and inventory reduction. Remember, Meyka AI is an AI-powered market analysis platform and forecasts are model-based projections, not guarantees. Use the report to confirm or challenge the model view and size positions to risk tolerance and time horizon.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.